Modifications in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters After α-Particle-Emitting 227Th-trastuzumab Therapy of HER2-Expressing Ovarian Cancer Xenografts

Helèn Heyerdahl(Nordic Nanovector (Norway)), Jostein Dahle(Oslo University Hospital), Ellen Mengshoel Brevik, Kathrine Røe(Oslo University Hospital)
International Journal of Radiation Oncology*Biology*Physics
June 18, 2013
Cited by 9


Related Papers